Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GUID
2051
DELISTED
Guidance Software, Inc.
GUID
| $2.73M | ﹤0.01% |
385,700
+14,400
| +4% | +$91.8K |
|
2052
Compugen
CGEN
$228M
| $2.73M | ﹤0.01% |
534,900
+72,075
| +16% | +$432K |
|
2053
St. Joe Company
JOE
$3.89B
| $2.73M | ﹤0.01% |
143,600
-200
| -0.1% | -$3.83K |
|
|
CNSL
2054
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $2.72M | ﹤0.01% |
101,394
+56,900
| +128% | +$1.49M |
|
|
PBFX
2055
DELISTED
PBF LOGISTICS LP
PBFX
| $2.72M | ﹤0.01% |
149,332
+23,332
| +19% | +$440K |
|
|
TGA
2056
DELISTED
Transglobe Energy Corp
TGA
| $2.71M | ﹤0.01% |
1,604,100
+33,500
| +2% | +$61.8K |
|
2057
Eldorado Gold
EGO
$10.4B
| $2.71M | ﹤0.01% |
168,280
-157,580
| -48% | -$2.48M |
|
|
TECD
2058
DELISTED
Tech Data Corp
TECD
| $2.7M | ﹤0.01% |
31,842
+4,300
| +16% | +$357K |
|
|
TELL
2059
DELISTED
Tellurian Inc.
TELL
| $2.69M | ﹤0.01% |
239,000
+22,100
| +10% | +$134K |
|
|
VBTX
2060
DELISTED
Veritex Holdings
VBTX
| $2.68M | ﹤0.01% |
100,500
+47,300
| +89% | +$972K |
|
|
WLH
2061
DELISTED
WILLIAM LYON HOMES
WLH
| $2.68M | ﹤0.01% |
+140,800
| New | +$2.67M |
|
2062
Primis Financial Corp
FRST
$413M
| $2.68M | ﹤0.01% |
163,900
+96,600
| +144% | +$1.38M |
|
|
TGB
2063
Trekor Metals
TGB
$3.06B
| $2.67M | ﹤0.01% |
3,137,900
+490,700
| +19% | +$297K |
|
|
HDNG
2064
DELISTED
Hardinge Inc
HDNG
| $2.67M | ﹤0.01% |
241,400
-26,700
| -10% | -$280K |
|
|
TPCO
2065
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $2.67M | ﹤0.01% |
192,700
+79,200
| +70% | +$1.1M |
|
2066
International Bancshares
IBOC
$4.56B
| $2.67M | ﹤0.01% |
65,400
-68,600
| -51% | -$2.45M |
|
2067
Century Communities
CCS
$2.01B
| $2.67M | ﹤0.01% |
127,000
+65,900
| +108% | +$1.37M |
|
|
MORE
2068
DELISTED
Monogram Residential Trust, Inc.
MORE
| $2.66M | ﹤0.01% |
246,100
+161,000
| +189% | +$1.69M |
|
|
CTRL
2069
DELISTED
Control4 Corporation
CTRL
| $2.66M | ﹤0.01% |
260,700
+93,000
| +55% | +$1.06M |
|
|
PCOM
2070
DELISTED
Points.com Inc. Common Shares
PCOM
| $2.65M | ﹤0.01% |
347,560
-340
| -0.1% | -$2.58K |
|
|
VTTI
2071
DELISTED
VTTI Energy Partners LP
VTTI
| $2.65M | ﹤0.01% |
+164,317
| New | +$2.88M |
|
2072
Consumer Portfolio Services
CPSS
$205M
| $2.65M | ﹤0.01% |
517,900
+9,100
| +2% | +$43.7K |
|
2073
BK Technologies
BKTI
$277M
| $2.65M | ﹤0.01% |
111,480
+100
| +0.1% | +$2.55K |
|
2074
Comp X International
CIX
$385M
| $2.65M | ﹤0.01% |
164,400
+7,301
| +5% | +$89.3K |
|
|
MITT
2075
TPG Mortgage Investment Trust
MITT
$215M
| $2.64M | ﹤0.01% |
+51,417
| New | +$2.54M |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.